secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001649094-25-000084
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte shareholders re-elect all three Class II directors and approve officer exculpation
--------------------------------------------------------------------------------

- John Furey reelected with 120.7M For vs 0.4M Withheld; Jacks Lee 107.3M For vs 13.8M Withheld.
- Heath Lukatch, Ph.D. reelected with 99.2M For vs 21.9M Withheld.
- Deloitte & Touche ratified as auditor for FY2025 with 124.8M For, 0.2M Against.
- Advisory say-on-pay passed with 77.1M For, 44.0M Against, 4.0M broker non-votes.
- Amendment to certificate for officer exculpation approved with 112.3M For, 8.8M Against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000164909425000084/0001649094-25-000084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000164909425000084/pcvx-20250612.htm
  HTML page:      https://secwatch.observer/filing/0001649094-25-000084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer